Explore more topics
Public ownership evidence

Actuate Therapeutics, Inc. Common stock (ACTU) Ownership Disclosures

Read ACTU insider transactions, institutional 13F filings and Congressional disclosures with report dates, public availability and original receipts.

As of 2026-11-07T14:03:26.246Z

Jump to a section

Read one actual disclosure before using it

Show the table · 1 row, 6 columns

Scroll sideways to compare all columns. Select a heading to sort.

2026-11-022026-10-28DEMETRIADES JAMES T, Kairos SPV Fund LLC, Kairos Venture Investments, LLC, Kairos Venture Opportunities I, L.P., Kairos Venture Partners II, L.P., Kairos-Actuate SPV, L.P., THOMSON TODD SA95,673Not reported

First displayed source row from Recent Form 4 activity. The full bounded history and coverage notes remain below.

The displayed observation date is 2026-10-28 and its public availability date is 2026-11-02. Subtracting those calendar dates gives 5 days of disclosure lag. Historical public research can use the record from the availability date, rather than backdating knowledge to the observation date. The calendar-day difference does not assert an intraday publication time.

This row is code A: a award. An award is an acquisition but is not an open-market purchase. A purchase-following rule must not count it as code P.

Open the linked original receipts to verify the row, then inspect a second record before drawing a pattern. This public filing observation supplies source evidence, not a completed copy-trading return.

SEC 0001193125-26-443732 ↗SEC 0001193125-26-443732 ↗SEC 0001193125-26-443732 ↗

Recent Form 4 activity

Inspect all 32 displayed rows: Recent Form 4 activity

Scroll sideways to compare all columns. Select a heading to sort.

2026-11-022026-10-28DEMETRIADES JAMES T, Kairos SPV Fund LLC, Kairos Venture Investments, LLC, Kairos Venture Opportunities I, L.P., Kairos Venture Partners II, L.P., Kairos-Actuate SPV, L.P., THOMSON TODD SA95,673Not reported
2026-11-022026-10-28DEMETRIADES JAMES T, Kairos SPV Fund LLC, Kairos Venture Investments, LLC, Kairos Venture Opportunities I, L.P., Kairos Venture Partners II, L.P., Kairos-Actuate SPV, L.P., THOMSON TODD SA75,738Not reported
2026-11-022026-10-28DEMETRIADES JAMES T, Kairos SPV Fund LLC, Kairos Venture Investments, LLC, Kairos Venture Opportunities I, L.P., Kairos Venture Partners II, L.P., Kairos-Actuate SPV, L.P., THOMSON TODD SA259,572Not reported
2026-11-022026-10-28DEMETRIADES JAMES T, Kairos SPV Fund LLC, Kairos Venture Investments, LLC, Kairos Venture Opportunities I, L.P., Kairos Venture Partners II, L.P., Kairos-Actuate SPV, L.P., THOMSON TODD SA269,017Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA269,342Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA36,056Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA82,018Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA47,972Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA368,304Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA194,984Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA682,885Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA87,743Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA126,162Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA824,012Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA133,073Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA82,454Not reported
2026-10-302026-10-28BIOS Fund III NT, LP, BIOS Fund III QP, LP, BIOS Fund III, LPA64,995Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA269,342Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA36,056Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA82,018Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA47,972Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA368,304Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA194,984Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA682,885Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA87,743Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA126,162Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA824,012Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA133,073Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA82,454Not reported
2026-10-302026-10-28BIOS Actuate Co-Invest I, LP, BIOS Actuate Co-Invest II, LP, BIOS Fund I QP, LP, BIOS Fund I, LP, BIOS Fund II NT, LP, BIOS Fund II QP, LP, BIOS Fund II, LP, Bios 2024 Co-Invest, LP, Bios Actuate Co-Invest III, LP, Bios Clinical Opportunity Fund, LPA64,995Not reported
2026-10-292026-10-28SCHMITT DANIEL MP140,844Not reported
2026-10-292026-10-28SCHMITT DANIEL MP70,422Not reported

90-day public availability window, up to 50 records.

Recent institutional filing receipts

Inspect all 50 displayed rows: Recent institutional filing receipts

These are raw ticker-matched positions in recent 13F receipts, including amendments. They are not deduplicated current ownership totals. Open the manager profile to inspect its effective filing book.

Scroll sideways to compare all columns. Select a heading to sort.

JPL Wealth Management, LLC2026-06-302026-08-151$2None
ABS Investment Management LLC2026-06-302026-08-1573,186$111,975None
BIOS Capital Management, LP2026-06-302026-08-158,594,141$13,149,036None
BIOS Capital Management, LP2026-06-302026-08-151,455,855$2,227,458None
Qube Research & Technologies Ltd2026-06-302026-08-1515,256$23,342None
OSAIC HOLDINGS, INC.2026-06-302026-08-151,000$1,530None
JANE STREET GROUP, LLC2026-06-302026-08-1522,329$34,163None
JANE STREET GROUP, LLC2026-06-302026-08-1516,803$25,709None
HRT FINANCIAL LP2026-06-302026-08-1514,034$21,000None
SUSQUEHANNA INTERNATIONAL GROUP, LLP2026-06-302026-08-1528,182$43,118None
MILLENNIUM MANAGEMENT LLC2026-06-302026-08-1596,684$147,927None
Voss Capital, LP2026-06-302026-08-151,725,000$2,639,250None
Palogic Value Management, L.P.2026-06-302026-08-15100,000$153,000None
AQR CAPITAL MANAGEMENT LLC2026-06-302026-08-154$6None
AQR CAPITAL MANAGEMENT LLC2026-06-302026-08-15391$598None
AQR CAPITAL MANAGEMENT LLC2026-06-302026-08-15125,058$191,339None
AQR CAPITAL MANAGEMENT LLC2026-06-302026-08-15658$1,007None
AQR CAPITAL MANAGEMENT LLC2026-06-302026-08-151,308$2,001None
AQR CAPITAL MANAGEMENT LLC2026-06-302026-08-1574$113None
ROYAL BANK OF CANADA2026-06-302026-08-15452$1,000None
BRIDGEWAY CAPITAL MANAGEMENT, LLC2026-06-302026-08-1523,482$35,927None
GOLDMAN SACHS GROUP INC2026-06-302026-08-1535,498$54,312None
BARCLAYS PLC2026-06-302026-08-15420$643None
BARCLAYS PLC2026-06-302026-08-151$2None
WELLS FARGO & COMPANY/MN2026-06-302026-08-152,440$3,733None
WELLS FARGO & COMPANY/MN2026-06-302026-08-156$9None
VANGUARD CAPITAL MANAGEMENT LLC2026-06-302026-08-14393,433$601,952None
ABS Direct Equity Fund LLC2026-06-302026-08-1473,186$111,975None
Vanguard Global Advisers, LLC2026-06-302026-08-145,102$7,806None
UBS Group AG2026-06-302026-08-142,064$3,158None
UBS Group AG2026-06-302026-08-141,470$2,249None
Mariner, LLC2026-06-302026-08-1421,082$32,257None
Virtu Financial LLC2026-06-302026-08-1414,611$22,000None
SFMG, LLC2026-06-302026-08-1433,000$50,490None
BNP PARIBAS FINANCIAL MARKETS2026-06-302026-08-14990$1,515None
VANGUARD FIDUCIARY TRUST CO2026-06-302026-08-1454,497$83,380None
MORGAN STANLEY2026-06-302026-08-1481$124None
MORGAN STANLEY2026-06-302026-08-142,000$3,060None
MORGAN STANLEY2026-06-302026-08-14586$897None
MORGAN STANLEY2026-06-302026-08-14823$1,259None
FMR LLC2026-06-302026-08-1430$46None
FMR LLC2026-06-302026-08-143,257$4,983None
NORTHERN TRUST CORP2026-06-302026-08-1421,220$32,467None
Integrated Wealth Concepts LLC2026-06-302026-08-13181$278None
GEODE CAPITAL MANAGEMENT, LLC2026-06-302026-08-1318,459$28,242None
GEODE CAPITAL MANAGEMENT, LLC2026-06-302026-08-1394,095$143,965None
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO2026-06-302026-08-1318,518$28,333None
RHUMBLINE ADVISERS2026-06-302026-08-133,620$5,538None
JPMORGAN CHASE & CO2026-06-302026-08-137,626$12,049None
IEQ CAPITAL, LLC2026-06-302026-08-1213,890$21,252None

90-day public filing window, up to 50 source positions.

JPL Wealth Management, LLC ↗ABS Investment Management LLC ↗BIOS Capital Management, LP ↗BIOS Capital Management, LP ↗Qube Research & Technologies Ltd ↗OSAIC HOLDINGS, INC. ↗JANE STREET GROUP, LLC ↗JANE STREET GROUP, LLC ↗HRT FINANCIAL LP ↗SUSQUEHANNA INTERNATIONAL GROUP, LLP ↗

Recent Congressional disclosures

No matching Congressional transactions were returned in this source preview.

Show the table · 0 rows, 5 columns

Scroll sideways to compare all columns. Select a heading to sort.

No records are available for this view.

Bounded public source preview, up to 25 disclosed events.

How to read the disclosure dates

The tables report different things: insider transactions, institutional positions and Congressional transaction ranges. Read each table with its source dates and units. They cannot be added into a combined ownership percentage.

  1. Company insiders

    SEC Form 4 purchases, sales and awards report transactions and their public filing availability.

  2. Institutional managers

    13F reports disclose delayed quarter-end positions. They are not a record of trades between quarters.

  3. Congressional filers

    Periodic transaction reports disclose transaction dates and amount brackets. Public filing dates determine what researchers could know.

Institutional source directory ↗Congressional source directory ↗

Read the transaction codes

Awards use transaction code A, purchases P and sales S. An acquisition from an award is not the same as an open-market purchase. Joint filers may share a transaction. Use original receipts and availability dates to interpret the events.